200 related articles for article (PubMed ID: 25912780)
1. Resolution of Thoracic and Abdominal Lymphangioleiomyomas in a Patient With Lymphangioleiomyomatosis Treated With Sirolimus.
Cabeza Osorio L; Ruiz Cobos MÁ; Casanova Espinosa Á
Arch Bronconeumol; 2016 Jun; 52(6):329-30. PubMed ID: 25912780
[No Abstract] [Full Text] [Related]
2. Highly effective sirolimus therapy for abdominal lymphangioleiomyoma.
Lecuelle D; Basille D; Renard C; Saint F; Jounieaux V
Respir Med Res; 2019 May; 75():32-34. PubMed ID: 31262426
[No Abstract] [Full Text] [Related]
3. Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.
Taveira-DaSilva AM; Hathaway O; Stylianou M; Moss J
Ann Intern Med; 2011 Jun; 154(12):797-805, W-292-3. PubMed ID: 21690594
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sirolimus in lymphangioleiomyomatosis.
Burger CD
N Engl J Med; 2011 Jul; 365(3):271-2; author reply 272. PubMed ID: 21774717
[No Abstract] [Full Text] [Related]
5. Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.
Harari S; Elia D; Torre O; Bulgheroni E; Provasi E; Moss J
Chest; 2016 Aug; 150(2):e29-32. PubMed ID: 27502989
[TBL] [Abstract][Full Text] [Related]
6. SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS.
Hecimovic A; Jakopovic M; Pavlisa G; Jankovic M; Vukic-Dugac A; Redzepi G; Brcic L; Samarzija M; Gupta N
Lymphology; 2015 Jun; 48(2):97-102. PubMed ID: 26714374
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus for lymphangioleiomyomatosis lesions.
Egan JJ; Remund KF; Corris P
N Engl J Med; 2008 May; 358(18):1963-4; author reply 1964. PubMed ID: 18450609
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of sirolimus in lymphangioleiomyomatosis.
Kida Y
N Engl J Med; 2011 Jul; 365(3):271; author reply 272. PubMed ID: 21774718
[No Abstract] [Full Text] [Related]
9. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.
Yao J; Taveira-DaSilva AM; Jones AM; Julien-Williams P; Stylianou M; Moss J
Am J Respir Crit Care Med; 2014 Dec; 190(11):1273-82. PubMed ID: 25329516
[TBL] [Abstract][Full Text] [Related]
10. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.
Freitas CS; Baldi BG; Araújo MS; Heiden GI; Kairalla RA; Carvalho CR
J Bras Pneumol; 2015; 41(3):275-80. PubMed ID: 26176526
[TBL] [Abstract][Full Text] [Related]
11. Response of lymphangioleiomyomatosis to a mammalian target of rapamycin inhibitor (temsirolimus) -based treatment.
Piha-Paul SA; Hong DS; Kurzrock R
J Clin Oncol; 2011 Apr; 29(12):e333-5. PubMed ID: 21263090
[No Abstract] [Full Text] [Related]
12. Lymphangioleiomyomatosis.
Doubková M; Štefániková M; Čan V; Merta Z; Svoboda M
Klin Onkol; 2019; 32(5):367-374. PubMed ID: 31610670
[TBL] [Abstract][Full Text] [Related]
13. Lymphangioleiomyomatosis.
Sclafani A; VanderLaan P
N Engl J Med; 2018 Jun; 378(23):2224. PubMed ID: 29874537
[No Abstract] [Full Text] [Related]
14. Summaries for patients. Sirolimus therapy in patients with lymphangioleiomyomatosis.
Ann Intern Med; 2011 Jun; 154(12):I44. PubMed ID: 21690578
[No Abstract] [Full Text] [Related]
15. [Sporadic lymphangioleiomyomatosis: pulmonary and retroperitoneal manifestation].
Theilig DC; Poellinger A
Rofo; 2014 Jun; 186(6):613-4. PubMed ID: 24407709
[No Abstract] [Full Text] [Related]
16. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
Bissler JJ; McCormack FX; Young LR; Elwing JM; Chuck G; Leonard JM; Schmithorst VJ; Laor T; Brody AS; Bean J; Salisbury S; Franz DN
N Engl J Med; 2008 Jan; 358(2):140-51. PubMed ID: 18184959
[TBL] [Abstract][Full Text] [Related]
17. Durability of Sirolimus for Lymphangioleiomyomatosis.
Martirossian A; Shah S; Carrete L; Valle J; Valentine V
Am J Med Sci; 2017 Dec; 354(6):603-607. PubMed ID: 29208258
[TBL] [Abstract][Full Text] [Related]
18. A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.
Argula RG; Kokosi M; Lo P; Kim HJ; Ravenel JG; Meyer C; Goldin J; Lee HS; Strange C; McCormack FX;
Ann Am Thorac Soc; 2016 Mar; 13(3):342-9. PubMed ID: 26799509
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of sirolimus in lymphangioleiomyomatosis.
McCormack FX; Inoue Y; Moss J; Singer LG; Strange C; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Young LR; Kinder BW; Downey GP; Sullivan EJ; Colby TV; McKay RT; Cohen MM; Korbee L; Taveira-DaSilva AM; Lee HS; Krischer JP; Trapnell BC; ;
N Engl J Med; 2011 Apr; 364(17):1595-606. PubMed ID: 21410393
[TBL] [Abstract][Full Text] [Related]
20. [A rare cause of edema: sporadic lymphangioleiomyomatosis].
Frank H; Weiss W
Dtsch Med Wochenschr; 2013 Sep; 138(38):1892-5. PubMed ID: 24022453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
